NEW YORK (TheStreet) -- Quintiles Transnational Holdings (Q - Get Report) dipped 2.42% to $51.54 at 10:28 a.m. on Thursday after the company, the world's largest provider of biopharmaceutical development and commercial outsourcing services, priced the secondary public offering by some of its shareholders.
The shareholders will sell 15 million shares at $52 a share. The offering, which should close March 18, includes a 30-day option to purchase up to an additional 2.25 million shares.
Must Read: Warren Buffett's 10 Favorite Stocks
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts